Big Pharma celebrates new year by raising prices on over 250 drugs

(credit: Images Money)

Leading drug makers rang in the new year by once again raising list prices of their drugs—this time on more than 250 of them, according to an analysis reported by Reuters.

Data examined by healthcare research firm 3 Axis Advisors found that major drug makers including Pfizer Inc, GlaxoSmithKline PLC, and Sanofi SA, Bristol-Myers Squibb Co, Gilead Sciences Inc, and Biogen Inc hiked prices this week.

The larger price tags applied to a range of medications, from blood thinners to cancer therapies and treatments for respiratory conditions, HIV, arthritis, and multiple sclerosis.

Read 6 remaining paragraphs | Comments